News
Health on MSN1mon
How Peptides for Weight Loss Work: What You Should KnowMany peptide medications like glucagon-like peptide-1 (GLP-1) receptor agonists were initially developed to treat type 2 diabetes. One unexpected side effect of these drugs is weight loss.
News Medical on MSN3d
Study shows minimal lean muscle mass loss with GLP-1 and GLP-1/GIP therapy for weight lossNew research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...
SAN DIEGO, March 23, 2025 — Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss. Unfortunately, shortages and high costs ...
and promoting glucagon-like peptide-1 (GLP-1) release. This approach holds potential for MASH treatment while maintaining a good safety profile. In this study, the authors first used an ...
CordenPharma provides large-scale peptide manufacturing for the Dual GLP-1/GIP Receptor Agonist drug substance of VK2735. CordenPharma provides fill-finish for the drug candidate's subcutaneous ...
CordenPharma and Viking Therapeutics sign multi-year strategic partnership to support the commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735. CordenPharma provides large-scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback